查看購物車
  • English
  • Japanese
  • Korean
基因治療CDMO市場規模及預測（2021-2034年），全球及區域佔有率、趨勢和成長機會分析報告：按服務類型、最終用戶和地區分類
市場調查報告書
商品編碼
1997069

基因治療CDMO市場規模及預測（2021-2034年），全球及區域佔有率、趨勢和成長機會分析報告：按服務類型、最終用戶和地區分類

Gene Therapy CDMO Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 225 Pages | 訂單完成後即時交付

價格
基因治療CDMO市場預計將從2025年的26億美元成長到2034年的141.7億美元，2026年至2034年的複合年成長率（CAGR）為20.3%。推動市場擴張的關鍵因素包括慢性病和遺傳病患疾病的上升、監管核准和商業化進程的加速，以及企業外包基因治療生產的趨勢日益成長。此外，對個人化和罕見疾病治療需求的不斷成長預計將在不久的將來推動基因治療CDMO市場的新趨勢。

自動化數位化正在透過提高效率、擴充性和改進品管來變革市場。這些技術簡化了病毒載體生產和細胞增殖的處理流程，同時最大限度地減少了人為干預，從而應對個人化治療方法開發中出現的複雜挑戰。合約研發生產機構 (CDMO) 正在應用流程分析技術來即時監控操作，使其能夠在保持多種產品同步生產的同時調整製程方法。數位雙胞胎利用其預測能力來預測細胞在不同測試條件下的反應，從而有助於工廠製程的改進。賽多利斯 (Sartorius) 的 MODDE 軟體與 Ambr 15 生物反應器的結合，展示了數位雙胞胎技術如何透過虛擬孿生系統實現最佳化。在病毒載體最佳化過程中，精確調整 pH 值和細胞密度參數，顯著縮短了實驗週期，從八週縮短至三週，同時將感染滴度提高了十倍。

透過結合機器學習演算法和預測能力，CDMO（合約研發生產機構）可以實施預防措施，減少營運中斷，同時提高治療產品的品質和產量。 2024年10月，OmniaBio在加拿大安大略省漢密爾頓市開設了一座全新的商業化生產設施和人工智慧卓越中心。該設施佔地10萬平方英尺，是專注於細胞和基因療法生產的最大的CDMO之一。

基因治療生產領域的監管要求促使企業在整個生產過程中收集和分析大量資料。人工智慧和數位化工具能夠實現無縫的資料整合，確保所有監管審查所需的文件完整且準確。利用人工智慧和數位化平台的合約研發生產機構（CDMO）可以有效應對複雜的監管申報流程，同時滿足不斷變化的行業要求。

自動化、人工智慧和數位分析系統的結合已成為CDMO實現營運效率的關鍵方法，並且正在成為基因治療CDMO市場的重要趨勢。

最終使用者的見解

從終端用戶角度來看，基因治療CDMO市場可細分為製藥公司、生物製藥公司和其他終端用戶。預計到2025年，生物製藥公司將佔據基因治療CDMO市場最大的佔有率。基因治療CDMO市場主要由生物製藥公司主導，其中包括小規模的生物技術公司和Start-Ups，它們在產品開發和生產活動中需要外部支援。推動這一市場擴張的因素包括內部生產能力不足、研發成本高昂以及基因治療本身的複雜性——基因治療通常需要企業本身不具備的專業醫療設施和專業知識。企業正在利用外包來改善臨床研發流程，同時維持研發預算。隨著基因治療研發管線的擴展（一些管線擁有數千個在研計畫），生物技術公司對病毒載體生產、製程最佳化和GMP生產服務的可靠合作夥伴的需求不斷成長。例如，與Lonza和Catalent等大型CDMO的合作，為腫瘤和罕見疾病領域的眾多生物技術項目提供支援。吉利德科學公司（透過其子公司Kite Pharma）和安進公司也在基因修飾療法的先進開發過程中利用CDMO服務。生技公司正在利用CDMO服務來克服監管方面的挑戰，這使它們能夠更快地將產品推向市場，進而推動基因治療CDMO市場的成長。

目錄

第1章執行摘要

  • 分析師市場展望
  • 市場吸引力

第2章：基因治療CDMO市場現狀

  • 價值鏈分析
  • 供應鏈分析
    • 製造商/供應商列表
    • 潛在客戶名單（最多 50 家公司）
  • 波特五力分析
  • PEST分析
  • 主要國家的進出口分析（基於最接近的HS編碼）
    • 主要國家的進出口分析
  • 人工智慧（AI）的影響
  • 產品或技術藍圖
  • 永續發展與ESG趨勢
  • 專利分析
  • 法律規範

第3章 競爭情勢

  • 主要企業進行標竿分析
  • 市佔率分析（2025 年）－按主要企業分類
  • 市場集中度

第4章 基因治療CDMO市場－主要市場動態

  • 市場促進因素
    • 慢性病和遺傳性疾病盛行率增加
    • 監管核准和商業化激增
    • 企業將基因療法生產外包的趨勢日益成長。
  • 市場限制因素
    • 高昂的製造成本
    • 製造過程的複雜性
    • 複雜的監管和合規要求
  • 市場機遇
    • 創新治療方法的臨床試驗增加
    • 各公司的策略舉措
    • 商業製造服務的擴展
  • 未來趨勢
    • 先進的自動化數位化
    • 對罕見疾病個人化醫療和治療的需求
    • 可擴展的病毒載體和下一代生產技術
  • 促進因素和抑制因素的影響

第5章 基因治療CDMO市場—全球市場分析

  • 2021-2034年基因治療CDMO市場收入
  • 基因治療CDMO市場預測與分析

第6章：基因治療CDMO市場收入分析－服務類型

  • 按服務類型分類的基因治療CDMO市場預測與分析
    • 藥物研發與生產
      • 藥物開發與生產：基因治療CDMO市場－收入，2021-2034年
    • 測試和監管服務
      • 檢測與監管服務：基因治療CDMO市場－收入，2021-2034年
    • 其他服務類型
      • 其他服務類型：基因治療CDMO市場 - 收入，2021-2034年

第7章 基因治療CDMO市場收入分析—最終用戶

  • 按最終用戶分類的基因治療CDMO市場預測與分析
    • 製藥公司
      • 製藥公司：基因治療CDMO市場－收入，2021-2034年
    • 生物製藥公司
      • 生物製藥公司：基因治療CDMO市場－收入，2021-2034年
    • 其他最終用戶
      • 其他終端使用者：基因治療CDMO市場－收入，2021-2034年

第8章 基因治療CDMO市場—區域分析

  • 北美洲
    • 服務類型
    • 最終用戶
    • 美國市場
    • 加拿大市場
    • 墨西哥市場
  • 歐洲
    • 德國市場
    • 英國市場
    • 法國市場
    • 義大利市場
    • 西班牙市場
    • 其他歐洲市場
  • 亞太地區
    • 中國市場
    • 日本市場
    • 印度市場
    • 澳洲市場
    • 韓國市場
    • 亞太地區的其他國家
  • 中東和非洲
    • 沙烏地阿拉伯市場
    • 南非市場
    • 阿拉伯聯合大公國市場
    • 其他中東和非洲市場
  • 中美洲和南美洲
    • 巴西市場
    • 阿根廷市場
    • 其他南美洲和中美洲市場

第9章：基因治療CDMO市場的產業趨勢

第10章：基因治療CDMO市場－主要企業概況

  • WuXi Biologics Inc
  • Charles River Laboratories International Inc
  • Catalent Inc
  • Lonza Group AG
  • National Resilience Inc
  • Thermo Fisher Scientific Inc
  • AGC Biologics AS
  • Takara Bio Inc
  • FUJIFILM Holdings Corp
  • SK pharmteco Inc

第11章附錄

Product Code: TIPRE00042223

The gene therapy CDMO market size is expected to grow from US$ 2.60 billion in 2025 to US$ 14.17 billion by 2034; it is projected to register a CAGR of 20.3% during 2026-2034. The increasing prevalence of chronic and genetic diseases, surging regulatory approvals and commercialization, and growing popularity of outsourcing gene therapy manufacturing by companies are noteworthy factors contributing to the expansion of the gene therapy CDMO market size. Additionally, the growing demand for personalized and rare disease therapies are projected to bring new gene therapy CDMO market trends in the near future.

The market experiences a transformation because automation and digitalization bring better efficiency and scalability and improved quality control. The technologies solve complex challenges which arise from developing personalized therapies because they minimize the need for human participation while they streamline the procedures which handle viral vector production and cell expansion. CDMOs implement process analytical technologies to monitor their operations in real time which allows them to adjust their processing methods while maintaining simultaneous production of multiple items. Digital twins use their predictive capabilities to forecast how cells will react under different testing conditions, which helps to improve factory processes. The combination of Sartorius's MODDE software with Ambr 15 bioreactors demonstrates how digital twin technology enables optimization through virtual twin systems. The process of viral vector optimization achieved a significant reduction in experimental duration to three weeks from eight weeks while it generated a tenfold rise in infectious titer through precise adjustment of pH and cell density parameters.

The use of machine learning algorithms together with predictive capabilities enables CDMOs to implement proactive measures which decrease operational interruptions while enhancing the therapeutic product quality and quantity. In October 2024, OmniaBio opened its new commercial-ready manufacturing facility and AI center of excellence in Hamilton, Ontario, Canada. The facility which covers 100,000 square feet stands among the biggest CDMOs which focus on manufacturing cell and gene therapies.

The regulatory requirements for gene therapy manufacturing necessitate organizations to collect and analyze extensive data throughout their manufacturing processes. AI and digital tools enable seamless data integration, ensuring that all necessary documentation is complete and accurate for regulatory review. CDMOs that use AI together with digital platforms can effectively handle the complex nature of regulatory submission processes while they maintain compliance with changing industry requirements.

Automation together with artificial intelligence and digital analytics systems has become the key approach for CDMOs to achieve operational efficiency through their implementation, thereby emerging as a significant trend in the gene therapy CDMO market.

End User-Based Insights

Based on end user, the gene therapy CDMO market is segmented into pharmaceutical companies, biopharmaceutical companies, and other end users. The biopharmaceutical companies segment held the largest gene therapy CDMO market share in 2025. The gene therapy CDMO market is mainly controlled by biopharmaceutical companies which include small biotech firms and startup companies that need outside help for their product development and manufacturing activities. The company's expansion results from its incomplete internal capacity combined with expensive research and development expenses and the difficult nature of gene therapy treatments which need special medical facilities and expert technical knowledge that the company usually does not possess. The company uses outsourcing to improve its clinical pipeline development process while maintaining its budget for research and development activities. The expanding gene therapy pipeline, with thousands of assets in development, creates increasing demand as biotechs require trustworthy partners for their needs in viral vector production and process optimization and GMP manufacturing services. Key examples include collaborations with leading CDMOs like Lonza and Catalent which support numerous biotech programs in oncology and rare diseases. Gilead Sciences (via Kite Pharma) and Amgen have also used CDMO services for their advanced development of gene-modified therapies. The biotechs use CDMO services to overcome their regulatory challenges which enables them to bring products to market faster, thereby fueling the gene therapy CDMO market growth.

The World Health Organization and Australian Institute of Health and Welfare are among the primary and secondary sources referred to while preparing the gene therapy CDMO market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. Gene Therapy CDMO Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 Porter's Five Force Analysis
  • 2.5 PEST Analysis
  • 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
    • 2.6.1 Import-Export Analysis for Key Countries
  • 2.7 Impact of Artificial Intelligence (AI)
  • 2.8 Product or Technology Roadmap
  • 2.9 Sustainability and ESG Trends
  • 2.10 Patent Analysis
  • 2.11 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2025 - By Key Players
  • 3.3 Market Concentration

4. Gene Therapy CDMO Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic and Genetic Diseases
    • 4.1.2 Surging Regulatory Approvals and Commercialization
    • 4.1.3 Growing Popularity of Outsourcing Gene Therapy Manufacturing by Companies
  • 4.2 Market Restraints
    • 4.2.1 High Manufacturing Costs
    • 4.2.2 Complexities in Manufacturing Processes
    • 4.2.3 Complex Regulatory and Compliance Requirements
  • 4.3 Market Opportunities
    • 4.3.1 Increased Clinical Trials for Innovative Therapies
    • 4.3.2 Strategic Initiatives by Companies
    • 4.3.3 Expansion of Commercial Manufacturing Services
  • 4.4 Future Trends
    • 4.4.1 Advanced Automation and Digitalization
    • 4.4.2 Personalized and Rare Disease Therapies Demand
    • 4.4.3 Scalable Viral Vector and Next Gen Production Technologies
  • 4.5 Impact of Drivers and Restraints

5. Gene Therapy CDMO Market - Global Market Analysis

  • 5.1 Gene Therapy CDMO Market Revenue (US$ Million), 2021-2034
  • 5.2 Gene Therapy CDMO Market Forecast and Analysis

6. Gene Therapy CDMO Market Revenue Analysis -Service Type

  • 6.1 Gene Therapy CDMO Market Forecasts and Analysis by Service Type
    • 6.1.1 Drug Development and Manufacturing
      • 6.1.1.1 Overview
      • 6.1.1.2 Drug Development and Manufacturing: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)
    • 6.1.2 Testing and Regulatory Services
      • 6.1.2.1 Overview
      • 6.1.2.2 Testing and Regulatory Services: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)
    • 6.1.3 Other Service Types
      • 6.1.3.1 Overview
      • 6.1.3.2 Other Service Types: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)

7. Gene Therapy CDMO Market Revenue Analysis -End User

  • 7.1 Gene Therapy CDMO Market Forecasts and Analysis by End User
    • 7.1.1 Pharmaceutical Companies
      • 7.1.1.1 Overview
      • 7.1.1.2 Pharmaceutical Companies: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)
    • 7.1.2 Biopharmaceutical Companies
      • 7.1.2.1 Overview
      • 7.1.2.2 Biopharmaceutical Companies: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)
    • 7.1.3 Other End Users
      • 7.1.3.1 Overview
      • 7.1.3.2 Other End Users: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)

8. Gene Therapy CDMO Market - Geographical Analysis

  • 8.1 North America
    • 8.1.1 North America Gene Therapy CDMO Market Overview
    • 8.1.2 North America: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 8.1.3 North America: Gene Therapy CDMO Market- By Segmentation
      • 8.1.3.1 Service Type
      • 8.1.3.2 End User
    • 8.1.4 North America: Gene Therapy CDMO Market Breakdown by Countries
      • 8.1.4.1 United States Market
        • 8.1.4.1.1 United States: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.1.4.1.2 United States: Gene Therapy CDMO Market- By Segmentation
          • 8.1.4.1.2.1 Service Type
          • 8.1.4.1.2.2 End User
      • 8.1.4.2 Canada Market
        • 8.1.4.2.1 Canada: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.1.4.2.2 Canada: Gene Therapy CDMO Market- By Segmentation
          • 8.1.4.2.2.1 Service Type
          • 8.1.4.2.2.2 End User
      • 8.1.4.3 Mexico Market
        • 8.1.4.3.1 Mexico: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.1.4.3.2 Mexico: Gene Therapy CDMO Market- By Segmentation
          • 8.1.4.3.2.1 Service Type
          • 8.1.4.3.2.2 End User
  • 8.2 Europe
    • 8.2.1 Europe Gene Therapy CDMO Market Overview
    • 8.2.2 Europe: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 8.2.3 Europe: Gene Therapy CDMO Market- By Segmentation
      • 8.2.3.1 Service Type
      • 8.2.3.2 End User
    • 8.2.4 Europe: Gene Therapy CDMO Market Breakdown by Countries
      • 8.2.4.1 Germany Market
        • 8.2.4.1.1 Germany: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.1.2 Germany: Gene Therapy CDMO Market- By Segmentation
          • 8.2.4.1.2.1 Service Type
          • 8.2.4.1.2.2 End User
      • 8.2.4.2 United Kingdom Market
        • 8.2.4.2.1 United Kingdom: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.2.2 United Kingdom: Gene Therapy CDMO Market- By Segmentation
          • 8.2.4.2.2.1 Service Type
          • 8.2.4.2.2.2 End User
      • 8.2.4.3 France Market
        • 8.2.4.3.1 France: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.3.2 France: Gene Therapy CDMO Market- By Segmentation
          • 8.2.4.3.2.1 Service Type
          • 8.2.4.3.2.2 End User
      • 8.2.4.4 Italy Market
        • 8.2.4.4.1 Italy: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.4.2 Italy: Gene Therapy CDMO Market- By Segmentation
          • 8.2.4.4.2.1 Service Type
          • 8.2.4.4.2.2 End User
      • 8.2.4.5 Spain Market
        • 8.2.4.5.1 Spain: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.5.2 Spain: Gene Therapy CDMO Market- By Segmentation
          • 8.2.4.5.2.1 Service Type
          • 8.2.4.5.2.2 End User
      • 8.2.4.6 Rest of Europe Market
        • 8.2.4.6.1 Rest of Europe: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.6.2 Rest of Europe: Gene Therapy CDMO Market- By Segmentation
          • 8.2.4.6.2.1 Service Type
          • 8.2.4.6.2.2 End User
  • 8.3 Asia Pacific
    • 8.3.1 Asia Pacific Gene Therapy CDMO Market Overview
    • 8.3.2 Asia Pacific: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 8.3.3 Asia Pacific: Gene Therapy CDMO Market- By Segmentation
      • 8.3.3.1 Service Type
      • 8.3.3.2 End User
    • 8.3.4 Asia Pacific: Gene Therapy CDMO Market Breakdown by Countries
      • 8.3.4.1 China Market
        • 8.3.4.1.1 China: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.1.2 China: Gene Therapy CDMO Market- By Segmentation
          • 8.3.4.1.2.1 Service Type
          • 8.3.4.1.2.2 End User
      • 8.3.4.2 Japan Market
        • 8.3.4.2.1 Japan: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.2.2 Japan: Gene Therapy CDMO Market- By Segmentation
          • 8.3.4.2.2.1 Service Type
          • 8.3.4.2.2.2 End User
      • 8.3.4.3 India Market
        • 8.3.4.3.1 India: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.3.2 India: Gene Therapy CDMO Market- By Segmentation
          • 8.3.4.3.2.1 Service Type
          • 8.3.4.3.2.2 End User
      • 8.3.4.4 Australia Market
        • 8.3.4.4.1 Australia: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.4.2 Australia: Gene Therapy CDMO Market- By Segmentation
          • 8.3.4.4.2.1 Service Type
          • 8.3.4.4.2.2 End User
      • 8.3.4.5 South Korea Market
        • 8.3.4.5.1 South Korea: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.5.2 South Korea: Gene Therapy CDMO Market- By Segmentation
          • 8.3.4.5.2.1 Service Type
          • 8.3.4.5.2.2 End User
      • 8.3.4.6 Rest of APAC Market
        • 8.3.4.6.1 Rest of APAC: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.6.2 Rest of APAC: Gene Therapy CDMO Market- By Segmentation
          • 8.3.4.6.2.1 Service Type
          • 8.3.4.6.2.2 End User
  • 8.4 Middle East and Africa
    • 8.4.1 Middle East and Africa Gene Therapy CDMO Market Overview
    • 8.4.2 Middle East and Africa: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 8.4.3 Middle East and Africa: Gene Therapy CDMO Market- By Segmentation
      • 8.4.3.1 Service Type
      • 8.4.3.2 End User
    • 8.4.4 Middle East and Africa: Gene Therapy CDMO Market Breakdown by Countries
      • 8.4.4.1 Saudi Arabia Market
        • 8.4.4.1.1 Saudi Arabia: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.4.4.1.2 Saudi Arabia: Gene Therapy CDMO Market- By Segmentation
          • 8.4.4.1.2.1 Service Type
          • 8.4.4.1.2.2 End User
      • 8.4.4.2 South Africa Market
        • 8.4.4.2.1 South Africa: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.4.4.2.2 South Africa: Gene Therapy CDMO Market- By Segmentation
          • 8.4.4.2.2.1 Service Type
          • 8.4.4.2.2.2 End User
      • 8.4.4.3 United Arab Emirates Market
        • 8.4.4.3.1 United Arab Emirates: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.4.4.3.2 United Arab Emirates: Gene Therapy CDMO Market- By Segmentation
          • 8.4.4.3.2.1 Service Type
          • 8.4.4.3.2.2 End User
      • 8.4.4.4 Rest of Middle East and Africa Market
        • 8.4.4.4.1 Rest of Middle East and Africa: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.4.4.4.2 Rest of Middle East and Africa: Gene Therapy CDMO Market- By Segmentation
          • 8.4.4.4.2.1 Service Type
          • 8.4.4.4.2.2 End User
  • 8.5 South and Central America
    • 8.5.1 South and Central America Gene Therapy CDMO Market Overview
    • 8.5.2 South and Central America: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 8.5.3 South and Central America: Gene Therapy CDMO Market- By Segmentation
      • 8.5.3.1 Service Type
      • 8.5.3.2 End User
    • 8.5.4 South and Central America: Gene Therapy CDMO Market Breakdown by Countries
      • 8.5.4.1 Brazil Market
        • 8.5.4.1.1 Brazil: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.5.4.1.2 Brazil: Gene Therapy CDMO Market- By Segmentation
          • 8.5.4.1.2.1 Service Type
          • 8.5.4.1.2.2 End User
      • 8.5.4.2 Argentina Market
        • 8.5.4.2.1 Argentina: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.5.4.2.2 Argentina: Gene Therapy CDMO Market- By Segmentation
          • 8.5.4.2.2.1 Service Type
          • 8.5.4.2.2.2 End User
      • 8.5.4.3 Rest of South and Central America Market
        • 8.5.4.3.1 Rest of South and Central America: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.5.4.3.2 Rest of South and Central America: Gene Therapy CDMO Market- By Segmentation
          • 8.5.4.3.2.1 Service Type
          • 8.5.4.3.2.2 End User

9. Gene Therapy CDMO Market Industry Landscape

10. Gene Therapy CDMO Market - Key Company Profiles

  • 10.1 WuXi Biologics Inc
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Charles River Laboratories International Inc
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Catalent Inc
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Lonza Group AG
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 National Resilience Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Thermo Fisher Scientific Inc
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 AGC Biologics AS
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Takara Bio Inc
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 FUJIFILM Holdings Corp
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 SK pharmteco Inc
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments

11. Appendix

  • 11.1 Glossary
  • 11.4 Research Methodology and Approach
    • 11.4.1 Secondary Research
    • 11.4.2 Primary Research
    • 11.4.3 Market Estimation Approach
      • 11.4.3.1 Supply Side Analysis
      • 11.4.3.2 Demand Side Analysis
    • 11.4.4 Research Assumptions and Limitations
    • 11.4.5 Currency Conversion
  • 11.5 About The Insight Partners
  • 11.6 Market Intelligence Cloud

List Of Figures

  • Table 1. List of Patents and Description
  • Table 2. List of Regulatory Bodies and Organizations
  • Table 3. Ease of Doing Business: Key Country Rankings
  • Table 4. Market Share Analysis, 2025 - By Key Players
  • Table 5. Gene Therapy CDMO Market - Revenue, 2021-2025(US$ Million)
  • Table 6. Gene Therapy CDMO Market - Revenue Forecast, 2026-2034(US$ Million)
  • Table 7. Gene Therapy CDMO Market - Revenue, 2021-2025(US$ Million) - by Service Type
  • Table 8. Gene Therapy CDMO Market - Revenue Forecast, 2026-2034(US$ Million) - by Service Type
  • Table 9. Gene Therapy CDMO Market - Revenue, 2021-2025(US$ Million) - by End User
  • Table 10. Gene Therapy CDMO Market - Revenue Forecast, 2026-2034(US$ Million) - by End User
  • Table 11. North America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 12. North America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 13. North America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 14. North America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 15. North America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 16. North America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 17. United States: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 18. United States: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 19. United States: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 20. United States: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 21. Canada: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 22. Canada: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 23. Canada: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 24. Canada: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 25. Mexico: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 26. Mexico: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 27. Mexico: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 28. Mexico: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 29. Europe: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 30. Europe: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 31. Europe: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 32. Europe: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 33. Europe: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 34. Europe: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 35. Germany: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 36. Germany: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 37. Germany: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 38. Germany: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 39. United Kingdom: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 40. United Kingdom: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 41. United Kingdom: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 42. United Kingdom: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 43. France: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 44. France: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 45. France: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 46. France: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 47. Italy: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 48. Italy: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 49. Italy: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 50. Italy: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 51. Spain: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 52. Spain: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 53. Spain: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 54. Spain: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 55. Rest of Europe: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 56. Rest of Europe: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 57. Rest of Europe: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 58. Rest of Europe: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 59. Asia Pacific: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 60. Asia Pacific: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 61. Asia Pacific: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 62. Asia Pacific: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 63. Asia Pacific: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 64. Asia Pacific: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 65. China: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 66. China: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 67. China: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 68. China: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 69. Japan: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 70. Japan: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 71. Japan: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 72. Japan: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 73. India: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 74. India: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 75. India: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 76. India: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 77. Australia: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 78. Australia: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 79. Australia: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 80. Australia: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 81. South Korea: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 82. South Korea: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 83. South Korea: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 84. South Korea: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 85. Rest of APAC: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 86. Rest of APAC: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 87. Rest of APAC: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 88. Rest of APAC: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 89. Middle East and Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 90. Middle East and Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 91. Middle East and Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 92. Middle East and Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 93. Middle East and Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 94. Middle East and Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 95. Saudi Arabia: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 96. Saudi Arabia: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 97. Saudi Arabia: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 98. Saudi Arabia: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 99. South Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 100. South Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 101. South Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 102. South Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 103. United Arab Emirates: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 104. United Arab Emirates: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 105. United Arab Emirates: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 106. United Arab Emirates: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 107. Rest of Middle East and Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 108. Rest of Middle East and Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 109. Rest of Middle East and Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 110. Rest of Middle East and Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 111. South and Central America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 112. South and Central America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 113. South and Central America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 114. South and Central America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 115. South and Central America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 116. South and Central America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 117. Brazil: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 118. Brazil: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 119. Brazil: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 120. Brazil: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 121. Argentina: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 122. Argentina: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 123. Argentina: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 124. Argentina: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 125. Rest of South and Central America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
  • Table 126. Rest of South and Central America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
  • Table 127. Rest of South and Central America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 128. Rest of South and Central America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 129. Glossary - Gene Therapy CDMO Market